UTHealth Houston Research

April 8, 2025

UTHealth Houston researchers investigate how proteins that help cells survive hypoxia might be used as therapy for heart and lung diseases

Written By: Laura Frnka-Davis | Updated: April 8, 2025

Scientists at UTHealth Houston are investigating how the body naturally adapts to hypoxia – an insufficient oxygen supply to the body or specific organs – to develop new treatments for life-threatening heart and lung diseases.

April 1, 2025

New perioperative institute launches to make surgery safer

Written By: Kenny Bybee | Updated: April 1, 2025

UTHealth Houston announced the establishment of the Institute of Perioperative Medicine, which will span different schools, including McGovern Medical School at UTHealth Houston and McWilliams School of Biomedical Informatics at UTHealth Houston.

March 24, 2025

Correcting imbalance with the gut microbiota after stroke could reduce brain inflammation, open pathway to potential therapies

Written By: Deborah Mann Lake | Updated: March 24, 2025

An imbalance in ligands, which are molecules produced by the body and the gut microbiota, can affect a key receptor protein that plays a role in brain inflammation after stroke, according to researchers at UTHealth Houston, who recently published their preclinical findings in Nature Communications.

March 14, 2025

Stem cell trial for early Alzheimer’s disease begins at UTHealth Houston

Written By: Deborah Mann Lake | Updated: March 14, 2025

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway at UTHealth Houston.

March 13, 2025

UTHealth Houston among the nation’s best in research funding

Written By: Kenny Bybee | Updated: March 13, 2025

UTHealth Houston continues to rank among the nation’s top institutions for National Institutes of Health (NIH) research funding, according to the latest annual rankings from the Blue Ridge Institute for Medical Research.

February 12, 2025

New clinical trial at UTHealth Houston tests gene therapy vector that delivers drug aimed at stopping overactive bladder in patients with spinal cord injury

Written By: Deborah Mann Lake | Updated: February 12, 2025

A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann.

January 24, 2025

UTHealth Houston establishes Fetal Institute focused on clinical care, research discovery, and education to advance fetal medicine

Written By: Jeannette Sanchez | Updated: January 24, 2025

Five years after the first groundbreaking fetoscopic spina bifida repair surgery using an innovative patch pioneered by researchers at UTHealth Houston, the fetal medicine team is celebrating the more than 100 procedures performed by the physicians and the launch of the UTHealth Houston Fetal Institute.

January 15, 2025

Link between gene duplications and deletions within chromosome region and nonsyndromic bicuspid aortic valve disease found by UTHealth Houston researchers

Written By: Sydney Lowther | Updated: January 15, 2025

Large and rare duplications and deletions in a chromosome region known as 22q11.2, which involves genes that regulate cardiac development, are linked to nonsyndromic bicuspid aortic valve disease, according to a new study led by UTHealth Houston researchers.

January 13, 2025

Project to redesign clinical trials for neurologic conditions for underserved populations funded with $2.9M grant to UTHealth Houston

Written By: Deborah Mann Lake | Updated: January 13, 2025

In an effort to close the gap in neurological outcomes for underserved populations, a UTHealth Houston project funded with $2.9 million from the National Institutes of Health (NIH) will engage community partners to improve the design of clinical trials.

January 7, 2025

UTHealth Houston study reveals two new genes associated with variants linked to epilepsy, offering new hope for personalized therapies

Written By: Laura Frnka-Davis | Updated: January 7, 2025

New research led by UTHealth Houston scientists uncovered two genes associated with variants linked to epilepsy, which showed specific traits that make them promising diagnostic biomarkers. The study was recently published in Nature Communications.

Find a Doctor/Provider

Select an area

Patient Care

Patient Resources

New Patient?

Billing

Patient Services

1-855-877-2808

Customer Service Hours

Mon – Thu, 8 a.m. to 8 p.m.

Fri, 8 a.m. to 5 p.m.

Sat, 9 a.m. to 1 p.m.

CST time zone

Insurance

COVID-19

More

Alert!

News & Articles